pc semaglutide/glycine Semaglutide/Glycine/B12 0.5 ml Compounded Semaglutide + Glycine Injections

In clinical trials, patients lost an average of 15% of their body weight

Instead, the muscle loss observed reflects the general physiological response to weight reduction

Diagnostic evaluation may include: Detailed neurological examination assessing sensation, reflexes, and motor function Hemoglobin A1c measurement to evaluate recent glycemic control Vitamin B12 levels and methylmalonic acid (if B12 is borderline) Serum protein electrophoresis (SPEP) and immunofixation to screen for paraproteinemia Thyroid function tests, as hypothyroidism can contribute to neuropathic symptoms Comprehensive metabolic panel to assess renal and hepatic function Nerve conduction studies in selected cases with atypical features Management strategies focus on optimizing glycemic control, which remains the most evidence-based intervention for preventing and potentially improving diabetic neuropathy

The general recommendation is to stop the medication and contact your provider immediately about next steps

While it can be distracting, it is usually not cause for immediate concern